Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

Right arrow Help viewing high resolution images
Right arrow Return to article

Please click here to obtain permission to reproduce this image.

Click on image to view larger version.



Figure 4 Adenoviral vascular endothelial growth factor (AdVEGF-165) transfection does not alter skeletal myoblast (SKMB) engraftment. (A) Representative lanes from Western blot analyses of 50 µg of protein extract from whole hearts five days after sham operation (n = 3), or transplantation with 1 x 106 SKMB transfected with either AdLuciferase (n = 3) or AdVEGF-165 (n = 4) 18 h before transplantation using antibodies specific to either skeletal myocyte myosin heavy chain (MY-32) or the light chain of cardiac myosin. (B) Quantification of MY-32 bands from Western blot analysis in arbitrary units. Data represent mean ± SD. p = NS SKMB vs. SKMB + AdVEGF-165.





Right arrow Return to article

 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement